SEC Company Response from Citius Pharmaceuticals, Inc. (CTXR) (CIK 0001506251) (CTXR) — Jan 19, 2016
Citius Pharmaceuticals, Inc. (CTXR) (CIK 0001506251)
Date: Jan. 19, 2016 · CIK: 0001506251 · Accession: 0001477932-16-008140
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-206903
Letter
ctxr_corresp.htmCitius Pharmaceuticals. Inc.
63 Great Road
Maynard, MA 01754
January 19, 2016
EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Citius Pharmaceuticals, Inc.
Registration Statement on Form S-1
File No. 333-206903
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Citius Pharmaceuticals, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on January 21, 2016, or as soon thereafter as possible.
The Company hereby acknowledges the following:
·
that should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
·
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
·
the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Citius Pharmaceuticals, Inc.
By: /s/ Leonard Mazur
Leonard Mazur
Chief Executive Officer & President
Show Raw Text
CORRESP
1
filename1.htm
ctxr_corresp.htmCitius Pharmaceuticals. Inc.
63 Great Road
Maynard, MA 01754
January 19, 2016
EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Citius Pharmaceuticals, Inc.
Registration Statement on Form S-1
File No. 333-206903
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Citius Pharmaceuticals, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on January 21, 2016, or as soon thereafter as possible.
The Company hereby acknowledges the following:
·
that should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
·
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
·
the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Citius Pharmaceuticals, Inc.
By: /s/ Leonard Mazur
Leonard Mazur
Chief Executive Officer & President